- Business
- Indo Amines Limited (INDOAMIN.BO) manufactures, develops and supplies fine chemicals, specialty chemicals, performance chemicals, perfumery chemicals and active pharmaceutical ingredients worldwide. The company produces an extensive range of products including aliphatic amines such as cyclohexylamine, n-propylamine, di-n-propylamine and dimethylaminopropylamine; aromatic amines including benzylamine, dibenzylamine and p-toluidine; nitriles like propionitrile, butyronitrile and 3-methoxypropionitrile; alkyl halides such as n-butyl chloride and cyclohexyl chloride; fatty acids including oleic acid, coconut fatty acid and soya fatty acid; amines and derivatives like lauryl amine, di-lauryl amine and tallow triamine; quaternary ammonium compounds including dodecyl trimethyl ammonium chloride and benzalkonium chloride; as well as morpholines, ethanolamines, cyclohexanols and other intermediates for pharmaceuticals, agrochemicals, fertilizers, petrochemicals, pesticides, dyes, detergents, personal care and road construction applications. Incorporated in 1994 and headquartered in Dombivli, Maharashtra, India, the company operates six manufacturing facilities in India at Dombivli, Dhule, Rabale, Baroda, Tarapur and Mahad, with four additional sites under development to support capacity expansion, and serves domestic and international markets through a diversified customer base.
In recent developments, Indo Amines completed the National Company Law Tribunal-approved amalgamation of Pious Engineering Private Limited in 2024, integrating operations to strengthen its business structure. The company launched Morpholine and its derivatives in fiscal year 2025 at its Dhule facility, targeting enhanced domestic and export sales in the aliphatic amines category and contributing to a 5.7% share price increase upon announcement. Financial performance reflects growth with standalone net sales reaching Rs 278.46 crore in March 2025, up 12.85% year-over-year, and Q2 FY2026 total income at Rs 281.95 crore, up 2.7% year-over-year alongside a 31.3% rise in profit after tax to Rs 18.11 crore, driven by improved capacity utilization, product diversification and healthy customer orders.